Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.

PURPOSE In a previous study, both recoverin and heat shock cognate protein 70 (hsc 70) were found as autoantigens recognized by sera from four patients with cancer-associated retinopathy (CAR). This observation suggested that autoimmune reactions against recoverin and hsc 70 might be involved together in the pathogenesis of CAR. The purpose of the present study is to investigate the effects of these autoantibodies on retinas in vivo. METHODS Functional and morphologic properties of the retinas were evaluated after anti-recoverin and/or anti-hsc 70 antibodies were intravitreously injected into Lewis rats' eyes. RESULTS Responses in electroretinogram (ERG) of eyes penetrated with anti-hsc 70 antibody were comparable with the control, but those with anti-recoverin antibody were remarkably reduced during the 3-week period after the injection. Such anti-recoverin antibody-induced reduction was significantly enhanced by copenetration with anti-hsc 70 antibody. Immunofluorescence microscopy demonstrated that after intravitreal injection, anti-recoverin antibody penetrated toward the outer nuclear layer (ONL) and outer segments within 12 to 24 hours, and the presence of the antibody in the retina diminished during the next few days. Histopathology revealed significant thinning of the ONL and inner nuclear layer (INL) in the affected retina in comparison with the control. Throughout the ONL and INL, apoptotic cells were recognized by TdT-dUTP terminal nick-end labeling. The antibody-induced retinal dysfunction was effectively treated by administrations of either corticosteroid or cyclosporin A. CONCLUSIONS These observations suggest that anti-recoverin- and anti-hsc 70 antibody-induced retinal dysfunction in Lewis rat is a good model to study the pathophysiology of CAR.

[1]  David J. Baylor,et al.  Mechanisms of rhodopsin inactivation in vivo as revealed by a COOH-terminal truncation mutant , 1995, Science.

[2]  A. Roth,et al.  The cancer-associated retinopathy antigen is a recoverin-like protein. , 1992, Investigative ophthalmology & visual science.

[3]  A. Roth,et al.  Intraperitoneal cultivation of small-cell carcinoma induces expression of the retinal cancer-associated retinopathy antigen. , 1993, Archives of ophthalmology.

[4]  K. Palczewski,et al.  A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy , 1991, The Journal of cell biology.

[5]  S. Tipping,et al.  A clinical triad to diagnose paraneoplastic retinopathy , 1990, Annals of neurology.

[6]  T. Parks,et al.  Type IIa ('anti‐Hu') antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro , 1993, Neurology.

[7]  R. Calne,et al.  The Use of Cyclosporin A Immunosuppression in Organ Grafting , 1982, Immunological reviews.

[8]  C. Thirkill.  Lung cancer-induced blindness. , 1996, Lung cancer.

[9]  K. Palczewski,et al.  Purification of Arrestin from Bovine Retinas , 1993 .

[10]  D. Alarcón-Segovia,et al.  Box 1. Autoantibodies that penetrate cells , 1996 .

[11]  J. Fujita,et al.  Characterization of a small‐cell‐lung‐carcinoma cell line from a patient with cancer‐associated retinopathy , 1996, International journal of cancer.

[12]  T. Mimura,et al.  Autoantibodies to human stress proteins. A survey of various rheumatic and other inflammatory diseases. , 1991, Arthritis and rheumatism.

[13]  A. Roth,et al.  Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. , 1993, Archives of ophthalmology.

[14]  A. Milam,et al.  Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. , 1998, American journal of ophthalmology.

[15]  J. Flannery,et al.  The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. , 1996, Clinical immunology and immunopathology.

[16]  A. Roth,et al.  Management and monitoring of cancer-associated retinopathy. , 1992, Archives of ophthalmology.

[17]  K. Palczewski,et al.  Calcium-Binding Proteins in the Retina , 1993 .

[18]  C. Thirkill.  Experimental, cancer-induced retinopathy. , 1996, Ocular immunology and inflammation.

[19]  A. Fauci,et al.  Glucocorticosteroid therapy: mechanisms of action and clinical considerations. , 1976, Annals of internal medicine.

[20]  D. Archer,et al.  An ultrastructural study of retinal photoreceptor degeneration associated with bronchial carcinoma. , 1984, American journal of ophthalmology.

[21]  C. M. Davenport,et al.  Rhodopsin mutations in autosomal dominant retinitis pigmentosa. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Larsson.  Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process. , 1980, Journal of immunology.

[23]  S. Koyasu,et al.  Autoantibodies to the heat-shock protein hsp90 in systemic lupus erythematosus. , 1988, The Journal of clinical investigation.

[24]  G. Adamus,et al.  Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. , 1998, Journal of autoimmunity.

[25]  G. Seigel,et al.  Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy. , 1997, Investigative ophthalmology & visual science.

[26]  A. Roth,et al.  Photoreceptor degeneration. Possible autoimmune disorder. , 1983, Archives of ophthalmology.

[27]  C. Chalk,et al.  Response of the Lambert‐Eaton myasthenic syndrome to treatment of associated small‐cell lung carcinoma , 1990, Neurology.

[28]  J. Winfield,et al.  Brief Definitive Report AUTOANTIBODIES TO THE CONSTITUTIVE 73-kD MEMBER OF THE hsp70 FAMILY OF HEAT SHOCK PROTEINS IN SYSTEMIC LUPUS ERYTHEMATOSUS , 2022 .

[29]  G. Weissmann,et al.  EFFECT OF DMSO ON THE STABILIZATION OF LYSOSOMES BY CORTISONE AND CHLOROQUINE IN VITRO * , 1967, Annals of the New York Academy of Sciences.

[30]  W. Hoyt,et al.  Blindness caused by photoreceptor degeneration as a remote effect of cancer. , 1976, American journal of ophthalmology.

[31]  R. Nussenblatt,et al.  Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats. , 1981, The Journal of clinical investigation.

[32]  S. Kornguth,et al.  Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. , 1986, Cancer research.

[33]  S. Kornguth,et al.  Occurrence of anti‐retinal ganglion cell antibodies in patients with small cell carcinoma of the lung , 1982, Cancer.

[34]  D. Meller,et al.  Effects of allopurinol and steroids on inflammation and oxidative tissue damage in experimental lens induced uveitis: a biochemical and morphological study. , 1996, The British journal of ophthalmology.

[35]  D. Dacey,et al.  Recoverin immunoreactivity in mammalian cone bipolar cells , 1993, Visual Neuroscience.

[36]  B. O'neill,et al.  Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies. , 1990, Mayo Clinic proceedings.

[37]  P. Hargrave,et al.  Role of anti-recoverin autoantibodies in cancer-associated retinopathy. , 1993, Investigative ophthalmology & visual science.

[38]  S. Nef,et al.  Regulation of rhodopsin phosphorylation by a family of neuronal calcium sensors. , 1995, Biochemical and Biophysical Research Communications - BBRC.

[39]  H. Ohguro.  High levels of rhodopsin phosphorylation in missense mutations of C‐terminal region of rhodopsin , 1997, FEBS letters.

[40]  L. Baizer,et al.  Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Roth,et al.  Cancer-associated retinopathy. , 1987, Archives of ophthalmology.

[42]  S. Lindquist.  The heat-shock response. , 1986, Annual review of biochemistry.

[43]  F. Hartl.  Molecular chaperones in cellular protein folding , 1996, Nature.

[44]  Satoru Kawamura,et al.  Rhodopsin phosphorylation as a mechanism of cyclic GMP phosphodiesterase regulation by S-modulin , 1993, Nature.

[45]  K. Palczewski,et al.  Structural and Enzymatic Aspects of Rhodopsin Phosphorylation (*) , 1996, The Journal of Biological Chemistry.

[46]  S. Lindquist,et al.  The heat-shock proteins. , 1988, Annual review of genetics.

[47]  K. Palczewski,et al.  Opsins with mutations at the site of chromophore attachment constitutively activate transducin but are not phosphorylated by rhodopsin kinase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Roth,et al.  Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. , 1989, The New England journal of medicine.

[49]  H. Ohguro,et al.  Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy. , 1999, Investigative ophthalmology & visual science.

[50]  T. Appelboom,et al.  Antibodies to the constitutive 73-kd heat shock protein: a new marker of mixed connective tissue disease? , 1993, The American journal of medicine.